DOSE-RESPONSE STUDY OF THE EFFECT OF CIPROFIBRATE ON SERUM LIPOPROTEIN CONCENTRATIONS IN HYPERLIPOPROTEINEMIA

被引：25

作者：

OLSSON, AG

ORO, L

机构：

[1] KAROLINSKA HOSP, DEPT MED, S-10401 STOCKHOLM 60, SWEDEN

[2] ERSTA HOSP, DEPT MED, STOCKHOLM, SWEDEN

来源：

ATHEROSCLEROSIS | 1982年 / 42卷 / 2-3期

关键词：

D O I：

10.1016/0021-9150(82)90153-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：229 / 243

页数：15

共 12 条

[1] RESULTS OF ANIMAL STUDIES WITH CIPROFIBRATE, A NEW ORALLY EFFECTIVE HYPOLIPIDEMIC DRUG [J].

ARNOLD, A ;

MCAULIFF, JP ;

POWERS, LG ;

PHILLIPS, DK ;

BEYLER, AL .

ATHEROSCLEROSIS, 1979, 32 (02) :155-163

[2]

BEUMONT JL, 1970, B WORLD HEALTH ORGAN, V43, P891

[3]

Carlson K, 1973, J Clin Pathol Suppl (Assoc Clin Pathol), V5, P32

[4]

Carlson L A, 1979, Prog Biochem Pharmacol, V15, P238

[5] A COLORIMETRIC METHOD FOR ESTIMATING SERUM TRIGLYCERIDES [J].

FLETCHER, MJ .

CLINICA CHIMICA ACTA, 1968, 22 (03) :393-&

[6] ONE-YEAR STUDY OF EFFECT OF BEZAFIBRATE ON SERUM LIPOPROTEIN CONCENTRATIONS IN HYPERLIPOPROTEINEMIA [J].

OLSSON, AG ;

LANG, PD .

ATHEROSCLEROSIS, 1978, 31 (04) :429-433

[7] DOSE-RESPONSE STUDY OF BEZAFIBRATE ON SERUM LIPOPROTEIN CONCENTRATIONS IN HYPERLIPOPROTEINEMIA [J].

OLSSON, AG ;

LANG, PD .

ATHEROSCLEROSIS, 1978, 31 (04) :421-428

[8]

OLSSON AG, 1980, ARTERY, V7, P215

[9]

OLSSON AG, 1980, ARTERY, V7, P206

[10]

OLSSON AG, 1980, ACTA MED SCAND S, V637

← 1 2 →